Structural

Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023

17 min.

Does Mild PVL Really Matter and What Can Be Done About It?

14 min.

Minimalist TAVR And What It Means for Procedural Optimization in 2023

12 min.

When Do I Really Need a Cardiac Catheterization in Anticipation of TAVR?

13 min.

Where It All Begins: Valve Clinic and the Multidisciplinary Heart Team

8 min.

Prophylactic Antithrombotic Therapy After TAVR

12 min.

Defining Valve Thrombosis: Making Sense of Alphabet Soup

5 min.

A Challenging Case of Clinical Valve Thrombosis

3 min.

Clinical Valve Thrombosis: Diagnosis, Management, and Prognosis

14 min.

I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?

9 min.

Technical Considerations for Index TAVR in a Younger Patient

15 min.

Position 3: Initial TAVR

16 min.

Position 2: Initial SAVR With Bioprosthetic Valve/Ross

5 min.

Position 1: Initial SAVR With Mechanical Valve

6 min.

Case Presentation: 59-Year-Old Male With Trileaflet Aortic Valve Stenosis

4 min.

Lifetime Management of AS: What Do the Patients Want?

15 min.

We Need an RCT, and Here Is How I Would Like to Design It

7 min.

Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management

10 min.

Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy

2 min.

Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS

7 min.

Moderate AS in HFrEF: Time to Treat Is Now

15 min.

Pharmacotherapy to Slow AS Progression and Protect the Heart

9 min.

EVOLVED: CMR As an Early Marker of Risk

6 min.

Imaging-Derived New Phenotypes of AS Severity

7 min.

Staging of Aortic Stenosis According to Cardiac Dysfunction

7 min.

EARLY TAVR

5 min.

Moderate AS With Heart Failure: TAVR UNLOAD

4 min.

Moderate AS With Cardiac Damage: The PROGRESS Trial

5 min.

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

8 min.

Updates on ECG-Based Algorithms

5 min.

“Access to Care” Issues in Aortic Stenosis Patients

10 min.

UPSTREAM Aortic Stenosis Management: Conceptual Framework

6 min.

TAVR vs SAVR in Low Gradient AS: Evidence Updates

18 min.

SAVR in Severe Aortic Stenosis With Small Aortic Annulus: What Are the Options?

11 min.

The Case For TAVR in Severe Aortic Stenosis With Small Aortic Annulus

7 min.

Discordant Echocardiographic and Invasive Hemodynamics in Aortic Stenosis: When Does It Matter?

16 min.

Diagnosing Low Gradient Aortic Stenosis: Time to Get It Right

16 min.

Multi-Valve and Concomitant Cardiovascular Disease: Gaps in the Guidelines

17 min.

Keynote: Structural Transcatheter Innovation from China: Highlights of New Valve Therapies Which Will Impact Clinical Practice

20 min.

High Surgical Risk Aortic Regurgitation: New TAVR Alternatives

11 min.

Moderate AS With Heart Failure: UNLOAD and Beyond

9 min.

Managing Heart Failure in AS With Multivalve Disease

10 min.

Low Flow - Low Gradient AS and Assessing Myocardial Reserve

15 min.

Recurrent Heart Failure After AVR: Causes and Treatment

8 min.

AS Reclassified According to Valve Function and Cardiac Disease

11 min.

Intro to Session

8 min.

Why Long-Term Valve Performance Matter

11 min.

Lifetime Management of Aortic Stenosis: The Importance of Choosing the First Valve

16 min.

Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial

9 min.

Case-Based Approach to Patients With Severe AS and MR (Degenerative and Functional)

11 min.

Considerations for Physiologic Testing to Assess CAD Severity in Patients With AS

8 min.

Position 2: TAVR With an Annular Valve

7 min.

Position 3: TAVR With a Supra-Annular Valve

6 min.

Position 1: SAVR With Root Enlargement

10 min.

Moderate AS With ‘At Risk’ Features: The PROGRESS Trial

5 min.

SPOTLIGHT LECTURE Staging of Aortic Stenosis According to Cardiac Dysfunction: Recent Updates

17 min.

UPSTREAM Aortic Stenosis Management: Conceptual Framework

9 min.

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

14 min.

Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure

16 min.

TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples

9 min.

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

11 min.

Bioskills: Understanding the Aortic Valve Anatomy and the Iteration with TAVR Devices

32 min.

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

8 min.

A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis : How Will Emerging Evidence Help Us?

3 min.

A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis: What Do the Guidelines Say?

4 min.

Patient Prosthesis Mismatch After TAVR – Does Valve Selection Matter in the Small Annulus?

8 min.

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

9 min.

Cerebral Embolic Protection: Why, When, and Who?

7 min.

Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?

7 min.

Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies

10 min.

The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis

13 min.

PENDING - CT-Guided ADR in a Calcium-Free LAD CTO Segment in a Post-TAVI/Post-CABG Patient

6 min.